BeStock  
Stocks › Biotechnology › IMMX

Immix Biopharma IMMX

US equityMarket cap rank #3420Biotechnology
$9.49 −$0.15 (-1.56%)
Pre-market · Oct 8, 8:50 am ET · After hours $9.49 0.00%
Open$9.50
Prev close$9.64
Day range$9.40 – $9.69
Volume1.38M
Market cap$788.42M
P/E (TTM)–
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings-10.8x
CheapRich

Near the bottom of its 5-year range · 13th percentile, 5-year average -5.8x

Price / book3.4x
CheapRich

Around its usual level · 54th percentile, 5-year average 6.2x

#3862 of 5317 stocks by PB (1 = cheapest)

P/E over five years

-55x-34x-14x7xDec '21May '24Oct '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$6.70
Price vs. fair value+41.7%Trading above the estimate
Star rating★★★☆☆
Economic moatNone
UncertaintyExtreme
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 3.44 – 6.23 54% (pricier than usual) #3862 of 5317 (1 = cheapest)
PE -10.78 -11.04 -5.81 13% (cheaper than usual) –
PS – – 0.00 – –

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Morningstar view

Star rating★★★
Fair value estimate$6.70
Economic moatNone
UncertaintyExtreme

Discussion

No comments yet — be the first to weigh in on IMMX.

Leave a comment

Scroll to Top